Increasing evidence shows that SMA patients have widespread DNA methylation abnormalities, which are not limited to the SMN2 gene but involve multiple genes related to the occurrence and development of the disease throughout the genome. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.